Zymeworks Inc (NAS:ZYME)
$ 9.38 0.23 (2.51%) Market Cap: 663.21 Mil Enterprise Value: 327.13 Mil PE Ratio: 0 PB Ratio: 1.47 GF Score: 78/100

Zymeworks Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 06:30PM GMT
Release Date Price: $8.67 (+5.22%)
Lut Ming Cheng
JPMorgan Chase & Co, Research Division - Research Analyst

Good morning, everyone. Thank you so much for joining us for a session at the 41st JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here at the firm. Presenting next is Zymeworks. And I'll turn over the stage to Zymeworks in a second, but the presentation will be followed by a Q&A session, and the stage is yours.

Kenneth H. Galbraith
Zymeworks Inc. - CEO & Chairman of the Board

Thank you very much. Good morning, everyone. Welcome to late Thursday morning on JPMorgan Conference and certainly appreciate the opportunity to present to you here. I know all of you have sat through a whole host of presentations this week just to get to this one, appreciate your patience in getting to this one. And I'm going to try and keep this light and flowing for you to the end and then leave a lot of time for questions, and I thought we got a good informal situation here to answer questions.

So with that, I'll proceed. This is our legal disclaimer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot